India coronavirus vaccine market is anticipated to witness double-digit CAGR in the forecast period, FY2023-FY2027. The growth in the market can be attributed to increased demand for preventive drugs and other related products; thereby supporting the growth of the India coronavirus vaccine market in the next five years. In the end of year 2019, the outbreak of COVID-19 was observed first in Wuhan City, China. The infection later spread rapidly in other Asian countries and by March 2020, World Health Organization (WHO) declared it a global pandemic. The world observed a complete lockdown that affected end user industries including healthcare. Healthcare facilities struggled with the administration of patients and their cure while the market for almost all other products and services were shutdown. Death toll that the pandemic caused and the number of complications the virus caused in other patients gave a warning toward the severity of the concerns, driving the growth of India coronavirus vaccine market. Moreover, governmental aid toward the vaccination, availability of the vaccines systematically to all the age groups are driving the market growth.

India is currently in the overdrive process of providing vaccination against COVID-19 through fast track development process. Although, more research is being conducted in order to confirm the cure of a particular virus and fight against coronavirus. Coronavirus vaccines safely deliver immunogen that is antigen specific which triggers human immune-response system Human immune-response system generates antibodies against the antigen and the B-cells are later stored as T-cells thereby creating a memory response for the viral pathogen. In case of any future infection by COVID-19 virulent, the immune system of the body responses based on the memory cell responses and fights off disease. Furthermore, research is being conducted to provide cost-effective vaccine with higher efficiency that can create most effective T-cells that will completely fight off the virus attack.

India coronavirus vaccine market is segmented by infection type, vaccine type, product type, route of administration, patient type, end user, regional distribution, and competitional landscape. Based on vaccine type, the market is further fragmented into virus vaccine, viral vector vaccine, nucleic acid vaccines, protein based vaccine, and others. Virus vaccines are the vaccines that use only a part or subunit of virus, whereas viral vector vaccine specifically contain the inactivated form of the only vector that mobilizes the virus in the human body. Nucleic acid vaccines are of two types, RNA based, and DNA based; to overcome COVID-19, nucleic acid vaccines are a new approach that contains only the genetic information of the virulent entity and is introduced in the body. Protein based vaccines are specific viral proteins that are produced by the genetic material of virus thereby these vaccines would generate antibodies that digest these proteins thus inactivating effects.

Some of the top players in the India coronavirus vaccine market include Serum Institute of India Pvt. Ltd., Bharat Biotech International Ltd., Zydus Cadila Ltd., Pfizer India Ltd., Panacea Biotec Ltd., Indian Immunologicals Ltd., Mynvax Pvt. Ltd., Biological E Ltd., Hetero Biopharma Ltd., Dr Reddy’s Laboratories Ltd., among others. The companies are involving themselves into research and development for the methods of better quality, and various quality analysis tests to provide the better products.

Years considered for this report:

Historical Years: FY2017 – FY2020

Base Year: FY2021

Estimated Year: FY2022

Forecast Period: FY2023 – FY2027

Objective of the Study:

  • To analyze the historical growth of the market size of India coronavirus vaccine market from FY2017 to FY2020.
  • To estimate and forecast the market size of India coronavirus vaccine market from FY2021 to FY2027 and growth rate until FY2027. 
  • To classify and forecast India coronavirus vaccine market based on infection type, vaccine type, product type, route of administration, patient type, end user, regional distribution, and competitional landscape.  
  • To identify dominant region or segment in the India coronavirus vaccine market.
  • To identify drivers and challenges for India coronavirus vaccine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India coronavirus vaccine market.
  • To identify and analyze the profile of leading players operating in India coronavirus vaccine market.
  • To identify key sustainable strategies adopted by market players in India coronavirus vaccine market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of India coronavirus vaccine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Coronavirus vaccine manufacturers, end users, and other stakeholders
  • Distributers and suppliers of Coronavirus vaccines and other stakeholders
  • Organizations, forums, and alliances related to coronavirus vaccines
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India coronavirus vaccine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Coronavirus Vaccine Market, By Infection Type:
    • SARS-CoV
    • MERS-CoV
    • SARS-CoV-2
  • India Coronavirus Vaccine Market, By Vaccine Type:

o   Virus vaccine

o   Viral vector vaccine

o   Nucleic acid vaccines

o   Protein based vaccine

o   Others

  • India Coronavirus Vaccine Market, By Product Type:

o   Monovalent Vaccine

o   Multivariant Vaccine

  • India Coronavirus Vaccine Market, By Route of Administration:

o   Oral

o   Intramuscular

o   Intranasal

  • India Coronavirus Vaccine Market, By Patient Type:

o   Pediatric

o   Adult

  • India Coronavirus Vaccine Market, By End User:

o   Hospitals

o   Clinics

o   Research Institutes

o   Others

  • India Coronavirus Vaccine Market, By Region:
    • South
    • West
    • North
    • East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India Coronavirus vaccine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Coronavirus Vaccine Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Voice of Customers

5.    India Coronavirus Vaccine Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value & Volume

5.2.  Market Share & Forecast

5.2.1.     By Type (mRNA Based, Non-Replicating Viral Vector Based, Inactivated Vaccine)

5.2.2.     By Patient Type (Adult v/s Pediatric)

5.2.3.     By End User (Hospitals, Clinics, Research Institutes, Others)

5.2.4.     By Region

5.2.4.1.         By State (Top 10 States)

5.2.5.     By Company (FY 2021)

5.3.  Product Market Map

6.    India mRNA Based Coronavirus Vaccine Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By End User

7.    India Non- Replicating Viral Vector Based Coronavirus Vaccine Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By End User

8.    India Inactivated Coronavirus Vaccine Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By End User

9.    Market Dynamics

9.1.     Drivers

9.2.     Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  Comparative Analysis of Approved Vaccines in the India

13.  Vaccination Scenario in the India

14.  Analysis of Prospective Vaccines (Vaccines in Clinical Trials)

15.  Import-Export Analysis

16.  Pricing Analysis

17.  India Economic Profile

18.  Competitive Landscape

18.1.    Competition Outlook

18.2.    Company Profiles (Includes the list of vaccine originators and those manufacturing vaccine on contractual basis in India)

18.2.1.  Serum Institute of India (SII)

18.2.2.  Biological E. Limited

18.2.3.  Cipla Ltd (Moderna’s Vaccine)

18.2.4.  Bharat Biotech International Limited

18.2.5.  Astra Zeneca Pharma India Limited

18.2.6.  Panacea Biotec Ltd.

18.2.7.  Hetero Biopharma Ltd.

18.2.8.  Virchow Biotech Private Limited

18.2.9.  Gland Pharma Limited

18.2.10.                Stelis Biopharma Pvt. Ltd.

19.  Strategic Recommendations

20.  About Us & Disclaimer